Article Details

Analysts See $-0.15 EPS for BioCryst Pharmaceuticals, Inc. (BCRX)

Retrieved on: 2018-02-16 05:33:45

Tags for this article:

Click the tags to see associated articles and topics

Analysts See $-0.15 EPS for BioCryst Pharmaceuticals, Inc. (BCRX). View article details on HISWAI:

Excerpt

<div><b>Aqr Capital Management</b> Limited Com invested in 0% or 66,119 shares. Legal General Grp Public Limited Co accumulated 21,553 shares or 0% of the stock. Tudor Corporation Et Al has 0.01% invested in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX). Geode Mngmt Limited Liability Company holds ...</div>

Article found on:

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up